Table 4.
Age, y | Sex | Euroscore II | MRT to surgery, y | NYHA | Surgical procedure | ECC time, min | Cross‐clamp time, min | Interval surgery‐death, d | Indication for rethoracotomy | Cause of death | Autopsy findings |
---|---|---|---|---|---|---|---|---|---|---|---|
82 | F | 3.60 | 23 | 3 | AVR | N/A | N/A | 4 | Hemothorax | Refractory shock | Diffuse myocardial damage and early hepatic necrosis |
82 | F | 2.97 | ⋯ | 2 | CABG + AVR | 237 | 135 | 2 | ⋯ | MOF after DC postinfarction after graft failure | ⋯ |
66 | F | 6.59 | 33 | 3 | CABG,AVR,MVR | 286 | 169 | 38 | Hemorrhage | MOF after LVF and RVF | ⋯ |
69 | F | 6.64 | 20 | 2 | AVR | 87 | 45 | 9 | ⋯ | MOF after Sepsis + forward and backward failure | ⋯ |
67 | F | 9.49 | 2 | 3 | ASD closure, PAPVC rerouting, TVP, MVP | 174 | 92 | 41 | Post‐CPR + signs of Mediastinitis | MOF with signs of systemic infection | Recent left ventricular infarction, lung edema, chronic DC, paravalvular dehiscention |
64 | F | 5.31 | 10 | 2 | ASD/VSD closure, MVR, TVP | 205 | 94 | 8 | First LVAD placement | MOF after cardiac and distributive shock | Generalized edema, signs of (sub)acute DC, toxic myocardial damage |
Second Hematoma |
Abbreviations: ASD, atrial septum defect; AVR, aortic valve replacement; CABG, coronary artery bypass graft surgery; CPR, cardiopulmonary resuscitation; DC, cardiac decompensation; ECC, extracorporal circulation time; F, female; LVAD, left ventricular assist device; LVF, left ventricle failure; min, minutes; MOF, multiorgan failure; MRT, mediastinal radiotherapy; MVP, mitral valve plasty; MVR, mitral valve replacement; N/A, not applicable; NYHA, New York Heart Association; PAPVC, partial anomalous pulmonary venous connection; RVF, right ventricle failure; TVP, tricuspid valve plasty; VSD, ventricular septum defect.